TCIM
ARLZ

TIAA CREF Investment Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

TIAA CREF Investment Management’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,610
Closed -$69K – 3141
2016
Q4 		$69K Sell
15,610
-94,530
-86% -$449K ﹤0.01% 3098
2016
Q3 		$534 Hold
110,140
– – ﹤0.01% 2821
2016
Q2 		$363K Sell
110,140
-172,911
-61% -$653K ﹤0.01% 2986
2016
Q1 		$1M Buy
+283,051
New +$1.46M ﹤0.01% 2475

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

TIAA CREF Investment Management's ARLZ Position: Q1 2017 in Review

TIAA CREF Investment Management sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q1 2017, closing a stake of 15,610 shares — an estimated $69K sold.

TIAA CREF Investment Management first reported a position in ARLZ in Q1 2016 and held it in 4 quarters. The position peaked at $1M in Q1 2016. 78 funds tracked by Wall St. Rank hold ARLZ as of Q1 2017.

  • TIAA CREF Investment Management reported no remaining Aralez Pharmaceuticals Inc. position as of Q1 2017 after selling out during the quarter.
  • TIAA CREF Investment Management sold 15,610 Aralez Pharmaceuticals Inc. shares in Q1 2017, an estimated $69K.
  • TIAA CREF Investment Management first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 4 quarters.
  • TIAA CREF Investment Management's Aralez Pharmaceuticals Inc. position peaked at $1M in Q1 2016.
  • 78 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q1 2017.

Based on TIAA CREF Investment Management's 13F filing for Q1 2017, filed 11 May 2017.